Benjamin Markman
Impact in
-
- HER2/EGFR in Cancer Research
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 2
- Lung Cancer Research Studies 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- José Baselga (3 shared papers)Violeta Serra (1 shared paper)Ludmila Prudkin (1 shared paper)Olga Rodríguez (1 shared paper)Marta Guzmán (1 shared paper)Sarai Rodríguez (1 shared paper)Pieter J.A. Eichhorn (1 shared paper)Maurizio Scaltriti (1 shared paper)
- Journals
- Annals of Oncology (8 papers)ESMO Open (1 paper)Oncogene (1 paper)European Journal of Cancer Supplements (1 paper)
- Partner nations
- AustraliaUnited StatesSpain
In The Last Decade
Benjamin Markman
12 papers receiving 642 citations
Peers
Comparison fields: 5 of 64
- Oncology 225
- Genetics 72
- Molecular Biology 407
- Pulmonary and Respiratory Medicine 129
- Cancer Research 55
Countries citing papers authored by Benjamin Markman
This map shows the geographic impact of Benjamin Markman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Markman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Markman more than expected).
Fields of papers citing papers by Benjamin Markman
This network shows the impact of papers produced by Benjamin Markman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Markman. The network helps show where Benjamin Markman may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Markman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 466 | |
| 2 | 2012 | 126 | |
| 3 | 2024 | 27 | |
| 4 | 2017 | 11 | |
| 5 | 2008 | 10 | |
| 6 | 2017 | 4 | |
| 7 | 2025 | 4 | |
| 8 | 2020 | 3 | |
| 9 | 2021 | 2 | |
| 10 | 2018 | 2 | |
| 11 | Membrane receptors as targets for therapeutic approaches in colorectal cancer | 2010 | 1 |
| 12 | 2020 | 1 |
About Benjamin Markman
Benjamin Markman is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 657 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), CAR-T cell therapy research (2 papers), Lung Cancer Research Studies (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Glycosylation and Glycoproteins Research (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Urinary and Genital Oncology Studies (1 paper). The work is most often cited by research in Oncology (225 citations), Genetics (72 citations), Molecular Biology (407 citations), Pulmonary and Respiratory Medicine (129 citations) and Cancer Research (55 citations). Benjamin Markman has collaborated with scholars based in Australia, United States and Spain. Frequent co-authors include José Baselga, Violeta Serra, Ludmila Prudkin, Olga Rodríguez, Marta Guzmán, Sarai Rodríguez, Pieter J.A. Eichhorn, Maurizio Scaltriti, Sarat Chandarlapaty and Joaquin Arribas. Their work appears in journals such as Annals of Oncology, ESMO Open, Oncogene and European Journal of Cancer Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.